Gilead Sciences Inc. 주가 추이
1
24일간의 Gilead Sciences Inc. 주가 이력을 보고 각 일별 주식 시가, 즉 거래일 거래소 개장 시 주식이 처음 거래되는 가격, day는 해당 기간 동안 거래된 최고 가격이며 최저 가격은 해당 기간 동안 거래된 최저 가격과 종가, 즉 Gilead Sciences Inc. 주식이 정상적인 거래 세션에서 거래되는 마지막 가격입니다. 테이블의 마지막 열에서 이전 종가에 대한 오늘의 종가 비율인 백분율 변화를 볼 수 있습니다.
Gilead Sciences 주식 정보
Gilead Sciences Inc. is a biopharmaceutical company that develops, produces and commercializes medicines against serious diseases. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), cancer, liver diseases, inflammatory and respiratory diseases and cardiovascular conditions. The main products produced by the company are: Sovaldi, Harvoni, Descovy, Odefsey, Genvoya, Complera / Eviplera, Zydelig, Letairis, Ranexa and others.
The Company's areas of focus include HIV, liver diseases, such as C virus (HCV) infection, chronic hepatitis and chronic hepatitis B virus (HBV) infection, hematology/oncology, cardiovascular, and inflammation/respiratory diseases. Gilead Sciences Inc. stocks are included in the Nasdaq-100, S & P 100 and S&P 500 company lists.
Gilead Sciences Inc was founded in June 1987 by Michael Riordan, a medical doctor who was 29 years old at the time.